APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Bordetella Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oral Bordetella Vaccine Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchOral Bordetella Vaccine Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Bordetella Vaccine Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Oral Bordetella Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Bordetella Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Bordetella Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Oral Bordetella Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oral Bordetella Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Bordetella Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Bordetella Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oral Bordetella Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oral Bordetella Vaccine market include Zoetis, Merck Animal Health, Boehringer Ingelheim(Merial) and Elanco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Bordetella Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Bordetella Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Bordetella Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Bordetella Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Bordetella Vaccine Segment by Company

Zoetis

Merck Animal Health

Boehringer Ingelheim(Merial)

Elanco

Oral Bordetella Vaccine Segment by Type

Combination Vaccine

Only Bordetella Vaccine

Oral Bordetella Vaccine Segment by Application

Puppies

Adult Dogs

Oral Bordetella Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oral Bordetella Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oral Bordetella Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral Bordetella Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Oral Bordetella Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Bordetella Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Bordetella Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Bordetella Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Bordetella Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Bordetella Vaccine industry.

Chapter 3: Detailed analysis of Oral Bordetella Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oral Bordetella Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oral Bordetella Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral Bordetella Vaccine Industry Trends Table 2. Oral Bordetella Vaccine Industry Drivers Table 3. Oral Bordetella Vaccine Industry Opportunities and Challenges Table 4. Oral Bordetella Vaccine Industry Restraints Table 5. Global Oral Bordetella Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral Bordetella Vaccine Revenue Share by Company (2021-2026) Table 7. Global Oral Bordetella Vaccine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Oral Bordetella Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Oral Bordetella Vaccine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Oral Bordetella Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oral Bordetella Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Oral Bordetella Vaccine Company, Product Type & Application Table 13. Global Oral Bordetella Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Bordetella Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Combination Vaccine Table 18. Significant Companies of Only Bordetella Vaccine Table 19. Global Oral Bordetella Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Oral Bordetella Vaccine Sales Volume by Type (2021-2026) & (k units) Table 21. Global Oral Bordetella Vaccine Sales Volume by Type (2027-2032) & (k units) Table 22. Global Oral Bordetella Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Oral Bordetella Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Oral Bordetella Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Oral Bordetella Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Oral Bordetella Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Oral Bordetella Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Oral Bordetella Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Puppies Table 30. Significant Companies of Adult Dogs Table 31. Global Oral Bordetella Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Oral Bordetella Vaccine Sales Volume by Application (2021-2026) & (k units) Table 33. Global Oral Bordetella Vaccine Sales Volume by Application (2027-2032) & (k units) Table 34. Global Oral Bordetella Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Oral Bordetella Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Oral Bordetella Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Oral Bordetella Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Oral Bordetella Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Oral Bordetella Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Oral Bordetella Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Oral Bordetella Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Oral Bordetella Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global Oral Bordetella Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Oral Bordetella Vaccine Sales by Region (2027-2032) & (k units) Table 45. Global Oral Bordetella Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Oral Bordetella Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Oral Bordetella Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Oral Bordetella Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Oral Bordetella Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Oral Bordetella Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Oral Bordetella Vaccine Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Oral Bordetella Vaccine Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Oral Bordetella Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Oral Bordetella Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Oral Bordetella Vaccine Sales by Country (2021-2026) & (k units) Table 56. Global Oral Bordetella Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Oral Bordetella Vaccine Sales by Country (2027-2032) & (k units) Table 58. Global Oral Bordetella Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Oral Bordetella Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Oral Bordetella Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Oral Bordetella Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Oral Bordetella Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Zoetis Company Information Table 64. Zoetis Business Overview Table 65. Zoetis Oral Bordetella Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Zoetis Oral Bordetella Vaccine Product Portfolio Table 67. Zoetis Recent Development Table 68. Merck Animal Health Company Information Table 69. Merck Animal Health Business Overview Table 70. Merck Animal Health Oral Bordetella Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Merck Animal Health Oral Bordetella Vaccine Product Portfolio Table 72. Merck Animal Health Recent Development Table 73. Boehringer Ingelheim(Merial) Company Information Table 74. Boehringer Ingelheim(Merial) Business Overview Table 75. Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Product Portfolio Table 77. Boehringer Ingelheim(Merial) Recent Development Table 78. Elanco Company Information Table 79. Elanco Business Overview Table 80. Elanco Oral Bordetella Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Elanco Oral Bordetella Vaccine Product Portfolio Table 82. Elanco Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. Oral Bordetella Vaccine Distributors List Table 86. Oral Bordetella Vaccine Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Oral Bordetella Vaccine Product Image Figure 2. Global Oral Bordetella Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Bordetella Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oral Bordetella Vaccine Sales (2021-2032) & (k units) Figure 5. Global Oral Bordetella Vaccine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Oral Bordetella Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Combination Vaccine Image Figure 10. Only Bordetella Vaccine Image Figure 11. Global Oral Bordetella Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Oral Bordetella Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Oral Bordetella Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Oral Bordetella Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Oral Bordetella Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Oral Bordetella Vaccine Sales Value Share by Type (2021-2032) Figure 17. Puppies Image Figure 18. Adult Dogs Image Figure 19. Global Oral Bordetella Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Oral Bordetella Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Oral Bordetella Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Oral Bordetella Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Oral Bordetella Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Oral Bordetella Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Oral Bordetella Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Oral Bordetella Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Oral Bordetella Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Oral Bordetella Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Oral Bordetella Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Oral Bordetella Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Oral Bordetella Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Oral Bordetella Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Oral Bordetella Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Oral Bordetella Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Oral Bordetella Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Oral Bordetella Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Oral Bordetella Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Oral Bordetella Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Oral Bordetella Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Oral Bordetella Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Combination Vaccine
  • Only Bordetella Vaccine
Applications
  • Puppies
  • Adult Dogs
Companies covered
  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim(Merial)
  • Elanco

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Bordetella Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Oral Bordetella Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Oral Bordetella Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oral Bordetella Vaccine Market Dynamics
  1. 2.1 Oral Bordetella Vaccine Industry Trends
  2. 2.2 Oral Bordetella Vaccine Industry Drivers
  3. 2.3 Oral Bordetella Vaccine Industry Opportunities and Challenges
  4. 2.4 Oral Bordetella Vaccine Industry Restraints
3 Oral Bordetella Vaccine Market by Company
  1. 3.1 Global Oral Bordetella Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Oral Bordetella Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Oral Bordetella Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Oral Bordetella Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Oral Bordetella Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Oral Bordetella Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Oral Bordetella Vaccine Company Product Type and Application
  8. 3.8 Global Oral Bordetella Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oral Bordetella Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oral Bordetella Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oral Bordetella Vaccine Market by Type
  1. 4.1 Oral Bordetella Vaccine Type Introduction
  2. 4.1.1 Combination Vaccine
  3. 4.1.2 Only Bordetella Vaccine
  4. 4.2 Global Oral Bordetella Vaccine Sales Volume by Type
  5. 4.2.1 Global Oral Bordetella Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oral Bordetella Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Oral Bordetella Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Oral Bordetella Vaccine Sales Value by Type
  9. 4.3.1 Global Oral Bordetella Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oral Bordetella Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Oral Bordetella Vaccine Sales Value Share by Type (2021-2032)
5 Oral Bordetella Vaccine Market by Application
  1. 5.1 Oral Bordetella Vaccine Application Introduction
  2. 5.1.1 Puppies
  3. 5.1.2 Adult Dogs
  4. 5.2 Global Oral Bordetella Vaccine Sales Volume by Application
  5. 5.2.1 Global Oral Bordetella Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oral Bordetella Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Oral Bordetella Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Oral Bordetella Vaccine Sales Value by Application
  9. 5.3.1 Global Oral Bordetella Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oral Bordetella Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Oral Bordetella Vaccine Sales Value Share by Application (2021-2032)
6 Oral Bordetella Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Oral Bordetella Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Bordetella Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Bordetella Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Oral Bordetella Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Oral Bordetella Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oral Bordetella Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oral Bordetella Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oral Bordetella Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Oral Bordetella Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oral Bordetella Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Oral Bordetella Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oral Bordetella Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Oral Bordetella Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oral Bordetella Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oral Bordetella Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oral Bordetella Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Oral Bordetella Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oral Bordetella Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oral Bordetella Vaccine Sales Value Share by Country, 2025 VS 2032
7 Oral Bordetella Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Oral Bordetella Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral Bordetella Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oral Bordetella Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Oral Bordetella Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Oral Bordetella Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Oral Bordetella Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oral Bordetella Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oral Bordetella Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oral Bordetella Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oral Bordetella Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oral Bordetella Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Oral Bordetella Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Oral Bordetella Vaccine Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Merck Animal Health
  8. 8.2.1 Merck Animal Health Company Information
  9. 8.2.2 Merck Animal Health Business Overview
  10. 8.2.3 Merck Animal Health Oral Bordetella Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Animal Health Oral Bordetella Vaccine Product Portfolio
  12. 8.2.5 Merck Animal Health Recent Developments
  13. 8.3 Boehringer Ingelheim(Merial)
  14. 8.3.1 Boehringer Ingelheim(Merial) Company Information
  15. 8.3.2 Boehringer Ingelheim(Merial) Business Overview
  16. 8.3.3 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim(Merial) Oral Bordetella Vaccine Product Portfolio
  18. 8.3.5 Boehringer Ingelheim(Merial) Recent Developments
  19. 8.4 Elanco
  20. 8.4.1 Elanco Company Information
  21. 8.4.2 Elanco Business Overview
  22. 8.4.3 Elanco Oral Bordetella Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Oral Bordetella Vaccine Product Portfolio
  24. 8.4.5 Elanco Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Bordetella Vaccine Value Chain Analysis
  2. 9.1.1 Oral Bordetella Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Bordetella Vaccine Sales Mode & Process
  6. 9.2 Oral Bordetella Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Bordetella Vaccine Distributors
  9. 9.2.3 Oral Bordetella Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst